Priscilla Ying Hsue MD

Adult Congenital Heart Disease

Associate Professor, Medicine, University of California, San Francisco, School of Medicine

100 Medical Plaza Driveway Suite 630Los Angeles, CA 90095
Phone+1 310-825-9011
Fax+1 415-206-3872

Dr. Hsue is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hsue's full profile Already have an account?

Education & Training

University of California (San Francisco)Fellowship, Cardiovascular Disease, 1999 - 2002
University of California (San Francisco)Residency, Internal Medicine, 1996 - 1999
University of California San Francisco School of MedicineClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1998 - 2028
American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients
COMPLETED
PHASE4
Effect of Maraviroc on Endothelial Function in HIV-Infected Patients
COMPLETED
PHASE3
Atherosclerosis in Rheumatoid Arthritis
COMPLETED

Publications & Presentations

PubMed

Neighborhood Socioeconomic Status and Heart Failure or All-Cause Readmission Within a Municipal Hospital System.
Diane Jeon, Matthew S Durstenfeld, Yifei Ma, Anjali B Thakkar, Priscilla Y Hsue
JACC. Advances. 2026-08-19
National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction.
Mohammad Keykhaei, Alexander T Sandhu, Priscilla Y Hsue, Stephen J Greene, Boback Ziaeian
JACC. Heart Failure. 2026-08-02
Delivering Quadruple Therapy for Heart Failure With Reduced Ejection Fraction in a Customizable Polypill: The COMBO-HF-X Pilot Randomized Trial.
Colette DeJong, Matthew S Durstenfeld, Jonathan D Davis, Christina S Wang, Elise D Riley
JACC. Heart Failure. 2026-07-09

Journal Articles

Association of Viral Persistence and Atherosclerosis in Adults with Treated HIV Infection
Jeffrey N Martin, Steven G Deeks, Priscilla Y Hsue, JAMA Network Open
Inflammation, Immunity, and Infection in Atherothrombosis
Paul M Ridker, Valentin Fuster, Priscilla Y Hsue, Peter Libby, ScienceDirect
Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Grou...
Steven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla Y Hsue, Eric S Daar, Ahmed Tawakol, Michael Lederman, Tanvir Bell, Clinical Infectious Diseases

Press Mentions

Aha Scientific Sessions: UCLA Health Experts Share New Advances in Heart Failure, Cardio-Oncology, and Arrhythmia CareNovember 7th, 2025
Injectable Medications Prove Effective at Lowering LDL CholesterolJanuary 17th, 2025
Chinese American Immigrants Face Higher Risk of Cardiovascular Disease Depending on Length of Residence and Location in the U.S.September 5th, 2024

Grant Support

Evaluation of Glucagon-Like Peptide-1 Receptor Agonist on Pathophysiology of Inflammation and Atherosclerosis in Persons Living With HIV: A Multicenter Randomized Placebo-Controlled TriUNIVERSITY OF CALIFORNIA LOS ANGELES2026–2031
Heart and Lung Outcomes Post-TB (HALO Post-TB)UNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRDVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)UNIVERSITY OF CALIFORNIA LOS ANGELES2023–2027